HIV SeropositivityHIV SeroprevalenceHIV InfectionsSubstance Abuse, IntravenousSexual BehaviorRisk FactorsDisease ProgressionSeroepidemiologic StudiesAntibodies, ViralAntibodies, BacterialChlamydophila pneumoniaeImmunoglobulin GChlamydophila InfectionsEnzyme-Linked Immunosorbent AssaySerologic TestsPrevalenceHIV SeronegativityNutritional StatusHelicobacter pyloriHelicobacter InfectionsCross-Sectional StudiesAcquired Immunodeficiency SyndromeCase-Control StudiesToxocariasisHIV-1Cohort StudiesAntibodies, ProtozoanProspective StudiesCytomegalovirus InfectionsHealth StatusAge FactorsTime FactorsToxoplasmosisHepatitis CHerpesvirus 2, HumanAIDS SerodiagnosisToxocaraFollow-Up StudiesBlood DonorsPapillomavirus InfectionsRural PopulationOdds RatioCD4 Lymphocyte CountBrazilMultivariate AnalysisNeosporaLogistic ModelsRetrospective StudiesCytomegalovirusStatus EpilepticusTreatment OutcomeHerpes GenitalisSyphilisHuman papillomavirus 16Immunoglobulin ACell CyclePrognosisHomosexualityToxoplasmaHomosexuality, MaleImmunoglobulin MIncidenceSocioeconomic FactorsUnited StatesSexual PartnersAnti-HIV AgentsPregnancyHepatitis A Virus, HumanViral LoadRisk-TakingBiological Markers